IC Tagged Articles

FDA should have acted faster to prevent contamination

Posted: June 9, 2009 Pharmaceutical

Leslie Fullerton provided the best care he could for his 29-month-old daughter Natalie with the medical equipment and medications provided him, but he still blames himself for her death. The little girl had already undergone a double-lung transplant and was

China says tainted drug blame should fall on foreign suppliers

Posted: May 27, 2009 Pharmaceutical

A Chinese senior health official says China has been unfairly labeled as a center for fake drug production and that blame should be placed instead on foreign companies who do business with unregistered firms against Chinese regulations. Bian Zhenijia, director

Surgeons hopeful about new alternatives to heparin

Posted: May 23, 2009 Pharmaceutical

Surgeons are anticipating the approval of new blood thinners that could replace more conventional methods currently in use, according to the Ortho SuperSite, a resource for orthopedic surgeons and rheumatologists.

FDA clears Baxter in deaths following heparin injections

Posted: May 22, 2009 Pharmaceutical

Baxter Healthcare Corp. has been cleared by the Food and Drug Administration (FDA) in the deaths of two patients at a Delaware hospital following an injection of the drug maker’s blood thinner heparin. The FDA attributed the two deaths, and

Baxter says it's not responsible for recent heparin deaths, illness

Posted: May 18, 2009 Pharmaceutical

It’s like a bad dream happening all over again – people falling ill or dying after receiving doses of the blood thinner heparin. In 2007, tainted doses of heparin killed more than 80 Americans and injured hundreds more. And while

New deaths, illness following heparin use spark FDA investigation

Posted: May 13, 2009 Pharmaceutical

The Food and Drug Administration (FDA) is testing batches of the blood thinner heparin after two people died and one became ill after receiving doses of the heparin, according to the Wall Street Journal. All three incidences occurred at the

Obama's pick for FDA commissioner wants to restore trust in agency

Posted: May 9, 2009 Pharmaceutical

President Barack Obama’s top pick for Food and Drug Administration (FDA) commissioner, Bioterrorsim expert and former New York City health commissioner Dr. Margaret Hamburg, says that she wants to restore public confidence in the FDA, according to Boston.com. She already

FDA approval for marketing generic Lovenox expected

Posted: May 8, 2009 Pharmaceutical

The expiration of exclusivity period for Sanofi Aventis’ blood thinner Lovenox has expired, moving Momenta Pharmaceutical Inc. one step closer to gaining approval from the Food and Drug Administration (FDA) to manufacture and market is generic Lovenox, M-Enoxaparin, according to

Congressman demands answers on tainted heparin scandal

Posted: May 6, 2009 Pharmaceutical

Rep. Joe Barton of Texas wants the Food and Drug Administration (FDA) to turn over databases stemming from last year’s tainted heparin scandal that killed more than 80 Americans and injured hundreds more, according to NASDAQ.com. At a public hearing

FDA accuses Chinese companies of lying about role in heparin scandal

Posted: April 20, 2009 Pharmaceutical

The Food and Drug Administrating (FDA) is accusing two Chinese pharmaceutical manufacturing companies of lying to federal regulators about their role in shipping batches of contaminated heparin into the United States between 2007 and 2008, according to Easy Bourse.